TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT05866562: Dupilumab in the Treatment of Pediatric Alopecia Areata

Sponsor: Icahn School of Medicine at Mount Sinai · Phase: PHASE2 · Area: DERMATOLOGY_AESTHETIC · Target Enrollment: 76 pts

Competing Trials Overlap

5 Active Trials

Excess Burn Exposure

$696,600

Rescue Site Savings

+$464,400

Unlock Full NCT05866562 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT05866562 Rescue Dossier →